These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32366855)

  • 1. The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism.
    Ye S; Xu P; Huang M; Chen X; Zeng S; Wang Q; Chen J; Li K; Gao W; Liu R; Liu J; Shao Y; Zhang H; Xu Y; Zhang Q; Zhong Z; Wei Z; Wang J; Hao B; Huang W; Liu Q
    Cell Death Dis; 2020 May; 11(5):312. PubMed ID: 32366855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductive carboxylation supports redox homeostasis during anchorage-independent growth.
    Jiang L; Shestov AA; Swain P; Yang C; Parker SJ; Wang QA; Terada LS; Adams ND; McCabe MT; Pietrak B; Schmidt S; Metallo CM; Dranka BP; Schwartz B; DeBerardinis RJ
    Nature; 2016 Apr; 532(7598):255-8. PubMed ID: 27049945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
    Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
    Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability.
    Wise DR; Ward PS; Shay JE; Cross JR; Gruber JJ; Sachdeva UM; Platt JM; DeMatteo RG; Simon MC; Thompson CB
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19611-6. PubMed ID: 22106302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Lactalbumin-oleic acid complex kills tumor cells by inducing excess energy metabolism but inhibiting mRNA expression of the related enzymes.
    Fang B; Zhang M; Ge KS; Xing HZ; Ren FZ
    J Dairy Sci; 2018 Jun; 101(6):4853-4863. PubMed ID: 29550120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nitroxide Tempol modulates anthracycline resistance in breast cancer cells.
    Gariboldi MB; Terni F; Ravizza R; Meschini S; Marra M; Condello M; Arancia G; Monti E
    Free Radic Biol Med; 2006 Apr; 40(8):1409-18. PubMed ID: 16631531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
    Ju R; Fei K; Li S; Chen C; Zhu L; Li J; Zhang D; Guo L; Ye C
    J Pharmacol Exp Ther; 2018 Oct; 367(1):20-27. PubMed ID: 30002095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of both mitochondrial isocitrate dehydrogenase enzymes in pancreatic beta cells inhibits insulin secretion.
    MacDonald MJ; Brown LJ; Longacre MJ; Stoker SW; Kendrick MA; Hasan NM
    Biochim Biophys Acta; 2013 Nov; 1830(11):5104-11. PubMed ID: 23876293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.
    Metallo CM; Gameiro PA; Bell EL; Mattaini KR; Yang J; Hiller K; Jewell CM; Johnson ZR; Irvine DJ; Guarente L; Kelleher JK; Vander Heiden MG; Iliopoulos O; Stephanopoulos G
    Nature; 2011 Nov; 481(7381):380-4. PubMed ID: 22101433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells.
    Jardim-Messeder D; Moreira-Pacheco F
    Anticancer Res; 2016 May; 36(5):2233-41. PubMed ID: 27127128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductive TCA cycle metabolism fuels glutamine- and glucose-stimulated insulin secretion.
    Zhang GF; Jensen MV; Gray SM; El K; Wang Y; Lu D; Becker TC; Campbell JE; Newgard CB
    Cell Metab; 2021 Apr; 33(4):804-817.e5. PubMed ID: 33321098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis.
    Yang Y; He P; Hou Y; Liu Z; Zhang X; Li N
    Phytomedicine; 2022 Jun; 100():154075. PubMed ID: 35413646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
    Wang L; Zhou H; Wang Y; Cui G; Di LJ
    Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox control of glutamine utilization in cancer.
    Alberghina L; Gaglio D
    Cell Death Dis; 2014 Dec; 5(12):e1561. PubMed ID: 25476909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of active elementary flux modes in mitochondria using selectively permeabilized CHO cells.
    Nicolae A; Wahrheit J; Nonnenmacher Y; Weyler C; Heinzle E
    Metab Eng; 2015 Nov; 32():95-105. PubMed ID: 26417715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism.
    Grassian AR; Parker SJ; Davidson SM; Divakaruni AS; Green CR; Zhang X; Slocum KL; Pu M; Lin F; Vickers C; Joud-Caldwell C; Chung F; Yin H; Handly ED; Straub C; Growney JD; Vander Heiden MG; Murphy AN; Pagliarini R; Metallo CM
    Cancer Res; 2014 Jun; 74(12):3317-31. PubMed ID: 24755473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withaferin A suppresses tumor promoter 12-O-tetradecanoylphorbol 13-acetate-induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cells.
    Li W; Zhao Y
    Cancer Sci; 2013 Feb; 104(2):143-8. PubMed ID: 23107437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide inhibits tumor growth by induction of cellular senescence.
    Li R; Zhang X; Tian X; Shen C; Zhang Q; Zhang Y; Wang Z; Wang F; Tao Y
    Oncol Rep; 2017 Jan; 37(1):442-448. PubMed ID: 27878302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells.
    Zhang Y; Lv W; Li Q; Wang Q; Ru Y; Xiong X; Yan F; Pan T; Lin W; Li X
    Mol Med Rep; 2019 Aug; 20(2):1893-1900. PubMed ID: 31257503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.